Learn, Analyse & Invest
only with
only with
+91
Download Orca
Fischer Medical Ventures Ltd.
Fischer Medical
₹ 0.00
0.00 (0.00)%
NSE
BSE
Trading
Small-cap - With a market cap of ₹24.92 Cr.
| EX-Date | Purpose |
|---|---|
| 28 06 2021 | Audited Results |
| 09 08 2021 | Quarterly Results |
| 10 11 2021 | Quarterly Results |
| 09 02 2022 | Quarterly Results |
| 30 05 2022 | Audited Results & Quarterly Results |
| 10 08 2022 | Quarterly Results |
| 17 11 2022 | Quarterly Results |
| 03 02 2023 | Inter alia, to consider and approve:- 1. The appointment of Non-Executive Independent Women Director, subject to necessary approval of shareholders. 2. The appointment of Non-Executive Independent Director, subject to necessary approval of shareholders. 3. The appointment of Executive Director subject to necessary approval of shareholders. 4. The appointment of Chief Financial Officer, Key Managerial Personnel. 5. Approve the appointment of Internal Auditor of the Company. 6. Approve the request for reclassification in accordance with Regulation 31A of the SEBI LODR Regulations received from Shri. Sankaranarayanan G M subject to approval of the shareholders and the Stock Exchanges. 7. Any other business with the permission of chairperson |
| 14 02 2023 | Quarterly Results |
| 30 03 2023 | Preferential Issue of shares |
| 29 05 2023 | Quarterly Results |
| 12 08 2023 | Quarterly Results |
| 01 11 2023 | Quarterly Results |
| 15 12 2023 | Inter alia, to consider and approve: 1. The proposal for fund raising by way of preferential issue / private placement of securities for cash / other than cash, including determination of Issue Price subject to such regulatory/statutory approvals as may be required, including the approval of shareholders of the Company.; 2. To transact other incidental and ancillary matters as may be decided by the board. |
| 12 02 2024 | Quarterly Results |
| 13 11 2024 | Quarterly Results |
| 03 01 2025 | Inter alia, to consider and approve:- 1. The withdrawal of the proposed preferential issue which was announced by the Company on December 26, 2024; 2. The proposal for fund raising by way of preferential issue / private placement of securities for cash / other than cash, including determination of Issue Price subject to such regulatory/statutory approvals as may be required, including the approval of shareholders of the Company.; 3. The day, date, time and venue for Extra-Ordinary General Meeting of the Company; 4. The notice for Extra-Ordinary General Meeting (EOGM) of the Company; 5. To fix the date for book closure (Register of Member); 6. To appoint Mr. Nuren Lodaya Practicing Company Secretary (Membership No. 60128), proprietor of M/s. Nuren Lodaya & Associates. as Scrutinizer for conducting e-voting and poll process for General Meeting of the Company; 7. To transact other incidental and ancillary matters as may be decided by the Board with the permission of Chairperson. |
| 14 02 2025 | Quarterly Results |
| 26 03 2025 | Inter alia, to consider the following:- 1. Noting the Resignation of Ms. Jeena Dineshchandra Suthar (DIN: 09852258) as Independent Director of the Company with effect from closing hours of 26 th March 2025. 2. Consider and Approve on the recommendation of Nomination and Remuneration Committee the Appointment of Ms. Jaya Ankur Singhania (DIN: 01990322) as Independent Director of the Company with effect from 26 th March 2025. 3. Consider and Approve the Notice of Postal Ballot with explanatory statements and other related matters. 4. Other General Business and ancillary matters. |
| 28 05 2025 | Final Dividend & Audited Results |
| 28 07 2025 | Stock Split |
| 14 08 2025 | A.G.M. & Quarterly Results |
| 28 10 2025 | Quarterly Results |
| 30 01 2026 | Quarterly Results |
News
